Andres J. Munoz-Martin

Madrid, MD 28007, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Cancer-Associated Thrombosis in Genitourinary Malignancies: A Real-World Analysis From the TESEO Registry.

Cancer-Associated Thrombosis in Genitourinary Malignancies: A Real-World Analysis From the TESEO Registry.

Journal: Archivos espanoles de urologia
Published: August 17, 2026

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Journal: Cancer treatment reviews
Published: May 16, 2026

Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group.

Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: April 03, 2026

MDM2 amplification in a real-world cohort of patients with biliary tract cancer from the Spanish RETUD gastrointestinal registry.

MDM2 amplification in a real-world cohort of patients with biliary tract cancer from the Spanish RETUD gastrointestinal registry.

Journal: ESMO gastrointestinal oncology
Published: February 06, 2026

Use of Information and Communication Technologies in Patients With Cancer Receiving Antineoplastic or Supportive Therapy: Comparative Cross-Sectional Survey.

Use of Information and Communication Technologies in Patients With Cancer Receiving Antineoplastic or Supportive Therapy: Comparative Cross-Sectional Survey.

Journal: Journal of medical Internet research
Published: December 25, 2025

Existing challenges in the management of cholangiocarcinoma in Spain.

Existing challenges in the management of cholangiocarcinoma in Spain.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 12, 2025

Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 03, 2025

Budget impact analysis of new drugs in oncology and haematology: Principles and practice.

Budget impact analysis of new drugs in oncology and haematology: Principles and practice.

Journal: British journal of clinical pharmacology
Published: August 07, 2025

PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 30, 2025

Gut microbiome and nutritional strategies in gastrointestinal cancers: Clinical implications and therapeutic perspectives.

Gut microbiome and nutritional strategies in gastrointestinal cancers: Clinical implications and therapeutic perspectives.

Journal: World journal of clinical oncology
Published: April 02, 2025

State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives.

State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives.

Journal: Expert opinion on biological therapy
Published: March 11, 2025
Showing 1-12 of 61

Last Updated: 09/26/2026